Product Information
VIENVA-28 TABLET is a generic product labeled by Xiromed LLC, priced at $0.1535 per EA under NDC 70700011885. Its NADAC has been published 408 times since Dec 12, 2018.
FDA first approved this application on May 21, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700011885
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201088FDA Approved
5/21/2015
TE Code
AB1
On Market Since
3/15/2018
Price Statistics
The NADAC for VIENVA-28 TABLET has been published 408 times since Dec 12, 2018, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.3780 (Sep 11, 2019) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.1992 |
| Average price | $0.2115 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 408 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VIENVA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIENVA-28 TABLET, manufactured by Xiromed LLC, is $0.1535 per EA (NDC 70700011885), effective Sep 30, 2026.
How has the price of VIENVA-28 TABLET changed over time?
Over the history we have for it, the NADAC for VIENVA-28 TABLET has declined 34.5%. It has been tracked across 408 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for VIENVA-28 TABLET?
Since Dec 12, 2018, the NADAC for VIENVA-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.3780 (Sep 11, 2019), with a median of $0.1992 per EA.
Are there cheaper alternatives to VIENVA-28 TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1135 per EA — about 26% below VIENVA-28 TABLET.
Who manufactures VIENVA-28 TABLET?
VIENVA-28 TABLET (NDC 70700011885) is labeled by Xiromed LLC, and CMS classifies it as a generic product.